Albumin Dialysis Without Anticoagulation in High-Risk Patients: An Observational Study

Artificial Organs

Volumn 36, Issue 3, 2012, Pages

  Tan, Han K ^a   Yang, Wen S ^a   Choong, Hui L ^a   Wong, Kok S ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Acute liver failure; Albumin dialysis; Anticoagulation; Heparin; Molecular Adsorbent Recirculating System

Indexed keywords

BLOOD; COAGULATION; DIALYSIS; PATIENT TREATMENT; RATS; UREA;

ACUTE LIVER FAILURE; ALBUMIN DIALYSIS; ANTI-COAGULATION; BLEEDINGS; CRITICALLY-ILL PATIENTS; HIGH-RISK PATIENTS; LIVER FAILURE; MOLECULAR ADSORBENT RECIRCULATING SYSTEM; OBSERVATIONAL STUDY; RECIRCULATING SYSTEM;

POLYSACCHARIDES;

AMMONIA; BILIRUBIN; CREATININE; HEPARIN; SODIUM CHLORIDE; UREA;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ALBUMIN DIALYSIS; AMMONIA BLOOD LEVEL; ANTICOAGULATION; ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD CLOTTING; BLOOD PRESSURE; CATHETER OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DISEASE EXACERBATION; FEMALE; FULMINANT HEPATIC FAILURE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTRAVASCULAR CATHETER; LENGTH OF STAY; MALE; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOCYTOPENIA; UREA BLOOD LEVEL;

EID: 84863236845     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01065.x     Document Type: Article

References (14)

1. Kurtovic J, Riordan SM, Williams R. Fulminant hepatic failure. Curr Treat Options Gastroenterol 2005;8:503-18.
2. Kelly DA. Managing liver failure. Postgrad Med J 2002;78:660-7.
3. Awad SS, Swanker F, Magee J, Punch J, Bartlett RH. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 2001;130:354-62.
4. Stange J, Mitzner SR, Risler T, etal. Molecular adsorbent recirculating system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
5. Davenport A, Will EJ, Davison AM. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron 1994;66:431-7.
6. Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000;26:1652-7.
7. Pavese P, Bonadona A, Beaubien J, etal. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Can J Anaesth 2005;52:26-9.
8. Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system (MARS). Artif Organs 2007;31:193-9.
9. Yang WS, Tan HK, Lui HF, Chow PK, Choong HL, Wong KS. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin. Artif Organs 2008;32:411-6.
10. Durao MS, Monte JC, Batista MC, etal. The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Crit Care Med 2008;36:3024-9.
11. Winrow RM, Davis C, Halldorson JB, Ahmad S. Intraoperative dialysis during liver transplantation with citrate dialysate. Hemodial Int 2009;13:257-60. Epub 2009 Jun 8.
12. Faybik P, Bacher A, Kozek-Langenecker SA, etal. Molecular adsorbent recirculating system and hemostatsis in patients at high risk of bleeding: an observational study. Crit Care 2006;10:R24.
13. Unger JK, Haltern C, Dohmen B, etal. Albumin and hydroxyethyl starch 130kDa/0.4 improves filter clearance and haemocompatibility in haemo- and plasmafiltration-an in vitro study. Nephro Dial Transplant 2005;20:1922-31.
14. Mazariegos GV, Kramer DJ, Lopez RC, etal. Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients. ASAIO J 2001;47:471-5.